Annual Revenue
$116.33 M
+$40.86 M+54.14%
31 December 2023
Summary:
Esperion Therapeutics annual revenue is currently $116.33 million, with the most recent change of +$40.86 million (+54.14%) on 31 December 2023. During the last 3 years, it has fallen by -$111.21 million (-48.87%). ESPR annual revenue is now -48.87% below its all-time high of $227.55 million, reached on 31 December 2020.ESPR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$51.63 M
-$22.20 M-30.07%
30 September 2024
Summary:
Esperion Therapeutics quarterly revenue is currently $51.63 million, with the most recent change of -$22.20 million (-30.07%) on 30 September 2024. Over the past year, it has increased by +$17.66 million (+52.00%). ESPR quarterly revenue is now -75.67% below its all-time high of $212.24 million, reached on 30 June 2020.ESPR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$295.45 M
+$17.66 M+6.36%
30 September 2024
Summary:
Esperion Therapeutics TTM revenue is currently $295.45 million, with the most recent change of +$17.66 million (+6.36%) on 30 September 2024. Over the past year, it has increased by +$192.55 million (+187.12%). ESPR TTM revenue is now at all-time high.ESPR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.1% | +52.0% | +187.1% |
| 3 y3 years | -48.9% | +258.3% | +306.5% |
| 5 y5 years | - | +5163.2% | +100.5% |
ESPR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -48.9% | +54.1% | -62.5% | +258.3% | at high | +337.8% |
| 5 y | 5 years | -48.9% | +54.1% | -75.7% | +5163.2% | at high | +6074.5% |
| alltime | all time | -48.9% | >+9999.0% | -75.7% | +5163.2% | at high | +6074.5% |
Esperion Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $51.63 M(-30.1%) | $295.45 M(+6.4%) |
| June 2024 | - | $73.83 M(-46.4%) | $277.79 M(+20.9%) |
| Mar 2024 | - | $137.74 M(+327.1%) | $229.74 M(+97.5%) |
| Dec 2023 | $116.33 M(+54.1%) | $32.25 M(-5.1%) | $116.33 M(+13.1%) |
| Sept 2023 | - | $33.97 M(+31.7%) | $102.90 M(+17.0%) |
| June 2023 | - | $25.79 M(+6.0%) | $87.91 M(+8.6%) |
| Mar 2023 | - | $24.33 M(+29.3%) | $80.97 M(+7.3%) |
| Dec 2022 | $75.47 M(-3.8%) | $18.82 M(-0.9%) | $75.47 M(+4.7%) |
| Sept 2022 | - | $18.98 M(+0.7%) | $72.06 M(+6.8%) |
| June 2022 | - | $18.84 M(+0.0%) | $67.49 M(-24.4%) |
| Mar 2022 | - | $18.84 M(+22.3%) | $89.31 M(+13.8%) |
| Dec 2021 | $78.45 M | $15.40 M(+6.9%) | $78.45 M(+7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $14.41 M(-64.6%) | $72.68 M(+17.0%) |
| June 2021 | - | $40.66 M(+409.6%) | $62.11 M(-73.4%) |
| Mar 2021 | - | $7.98 M(-17.2%) | $233.69 M(+2.7%) |
| Dec 2020 | $227.55 M(+53.4%) | $9.64 M(+151.4%) | $227.55 M(+4.0%) |
| Sept 2020 | - | $3.83 M(-98.2%) | $218.89 M(+1.3%) |
| June 2020 | - | $212.24 M(>+9900.0%) | $216.04 M(+4414.9%) |
| Mar 2020 | - | $1.84 M(+87.4%) | $4.79 M(-96.8%) |
| Dec 2019 | $148.36 M(>+9900.0%) | $982.00 K(+0.1%) | $148.36 M(+0.7%) |
| Sept 2019 | - | $981.00 K(-0.1%) | $147.38 M(+0.7%) |
| June 2019 | - | $982.00 K(-99.3%) | $146.40 M(+0.7%) |
| Mar 2019 | - | $145.42 M | $145.42 M |
| Dec 2000 | $2000.00(+100.0%) | - | - |
| Dec 1999 | $1000.00 | - | - |
FAQ
- What is Esperion Therapeutics annual revenue?
- What is the all time high annual revenue for Esperion Therapeutics?
- What is Esperion Therapeutics annual revenue year-on-year change?
- What is Esperion Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly revenue year-on-year change?
- What is Esperion Therapeutics TTM revenue?
- What is the all time high TTM revenue for Esperion Therapeutics?
- What is Esperion Therapeutics TTM revenue year-on-year change?
What is Esperion Therapeutics annual revenue?
The current annual revenue of ESPR is $116.33 M
What is the all time high annual revenue for Esperion Therapeutics?
Esperion Therapeutics all-time high annual revenue is $227.55 M
What is Esperion Therapeutics annual revenue year-on-year change?
Over the past year, ESPR annual revenue has changed by +$40.86 M (+54.14%)
What is Esperion Therapeutics quarterly revenue?
The current quarterly revenue of ESPR is $51.63 M
What is the all time high quarterly revenue for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly revenue is $212.24 M
What is Esperion Therapeutics quarterly revenue year-on-year change?
Over the past year, ESPR quarterly revenue has changed by +$17.66 M (+52.00%)
What is Esperion Therapeutics TTM revenue?
The current TTM revenue of ESPR is $295.45 M
What is the all time high TTM revenue for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM revenue is $295.45 M
What is Esperion Therapeutics TTM revenue year-on-year change?
Over the past year, ESPR TTM revenue has changed by +$192.55 M (+187.12%)